<DOC>
	<DOCNO>NCT02822053</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy ultrasonography ( US ) -guided laser ablation liver , kidney , pancreas , lung retroperitoneal tumor , investigator use preoperative postoperative US/CEUS/CT/MRI ass lesion , laboratory test include tumor marker evaluate general condition patient . Intraoperative US/CEUS/CT would apply monitor ablation lesion .</brief_summary>
	<brief_title>Effectivity Safety Ultrasound-guided Percutaneously Laser Ablation Refractory Neoplasms</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Patients small hepatocellular carcinoma ( single multiple nodule less 3 cm diameter ) , Patients ChildPugh A/B , Patients PLT ≥ 50*10E9/L PT ≤ 20 . Patients blood coagulation dysfunction , ChildPugh ≥3 , severe cardiopulmonary disease , intolerant anesthesia upper gastrointestinal bleeding shock .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Ultrasonography-guided Laser Ablation</keyword>
</DOC>